Improve speed to clinic and mitigate risk with appropriate analytical analysis View webinar here.
Scientific poster on orthogonal analytics for biosimilars
Reduce risk of biosimilar development with an orthogonal approach to physicochemical and bioanalytical methods
Read our latest white paper on using orthogonal methods during biosimilar development.
Read our article on the advances in biosimilar development. Read the full magazine here. *This article is taken from European Biopharmaceutical Review October 2016, pages 12-17. © Samedan Ltd
Our Senior Technical Marketing Manager, Brian Wendelburg recently wrote an article for Laboratory news discussing how successful biosimilar mAbs have been and the challenges that remain. To read the full article, click here.
Read our cell line development brochure.
In-depth profiling of IgG glycosylation coupled with ADCC assays enables generation of robust biosimilar comparability data Glasgow, UK – July 7, 2016: Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, announced the launched of a new Released N-Glycan Assay for the in-depth profiling of IgG glycosylation. This new physico-chemical assay, More
To help Indian researchers access a portfolio of excellent services from BioOutsource and Cellca Glasgow, UK – June 29, 2016: Sartorius Stedim Biotech (SSB), an international leading supplier for the biopharmaceutical industry, is pleased to announce that its subsidiary BioOutsource has appointed Ravin Mehta as Technical Sales Specialist to enable customers to have access to More
Cellca’s Cell Line and Upstream Process Development Services Now Integrated Glasgow, UK – June 14, 2016: Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry announced that its subsidiary BioOutsource launched an updated website to spotlight Sartorius Stedim Cellca’s cell line and upstream process development services for the biopharmaceutical industry. The new More
Click below to download.